|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/07/19 Organovo Holdings, Inc. 10-Q 9/30/19 60:6.3M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 627K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
43: R1 Document and Entity Information HTML 75K
13: R2 Condensed Consolidated Balance Sheets HTML 100K
30: R3 Condensed Consolidated Balance Sheets HTML 29K
(Parenthetical)
50: R4 Unaudited Condensed Consolidated Statements of HTML 72K
Operations and Other Comprehensive Loss
41: R5 Unaudited Condensed Consolidated Statements of HTML 60K
Stockholders' Equity
11: R6 Unaudited Condensed Consolidated Statements of HTML 102K
Cash Flows
28: R7 Description of Business HTML 30K
48: R8 Summary of Significant Accounting Policies HTML 67K
44: R9 Stockholders' Equity HTML 274K
24: R10 Collaborative Research, Development, and License HTML 27K
Agreements
20: R11 Commitments and Contingencies HTML 27K
35: R12 Leases HTML 126K
55: R13 Concentrations HTML 24K
25: R14 Related Parties HTML 26K
21: R15 Restructuring HTML 70K
36: R16 Subsequent Events HTML 27K
56: R17 Summary of Significant Accounting Policies HTML 83K
(Policies)
26: R18 Stockholders' Equity (Tables) HTML 269K
19: R19 Leases (Tables) HTML 120K
46: R20 Restructuring (Tables) HTML 70K
52: R21 Description of Business - Additional Information HTML 24K
(Detail)
33: R22 Summary of Significant Accounting Policies - HTML 140K
Additional Information (Detail)
15: R23 Stockholders' Equity - Schedule of Stock-based HTML 29K
Compensation Expense (Detail)
47: R24 Stockholders' Equity - Stock-based Compensation HTML 36K
Expense and Valuation Information - Additional
Information (Detail)
53: R25 Stockholders' Equity - Fair Value of Employee HTML 34K
Stock Options (Detail)
34: R26 Stockholders' Equity - Fair Value of Employee HTML 51K
Stock Purchase Plan (Detail)
16: R27 Stockholders' Equity - Fair Value of Employee HTML 24K
Stock Purchase Plan (Parenthetical) (Detail)
45: R28 Stockholders' Equity - Preferred Stock - HTML 24K
Additional Information (Detail)
54: R29 Stockholders' Equity - Common Stock - Additional HTML 64K
Information (Detail)
59: R30 Stockholders' Equity - Summary of Company's HTML 49K
Restricted Stock Unit Activity and
Performance-Based Restricted Stock Unit Activity
(Detail)
38: R31 Stockholders' Equity - Restricted Stock Awards, HTML 89K
Restricted Stock Units and Performance-Based
Restricted Stock Units - Additional Information
(Detail)
18: R32 Stockholders' Equity - Summary of Stock Option HTML 55K
Activity (Detail)
23: R33 Stockholders' Equity - Stock Options and Employee HTML 56K
Stock Purchase Plan - Additional Information
(Detail)
58: R34 Stockholders' Equity - Summary of Warrant Activity HTML 46K
(Detail)
37: R35 Stockholders' Equity - Warrants - Additional HTML 27K
Information (Detail)
17: R36 Stockholders' Equity - Common Stock Reserved for HTML 40K
Future Issuance (Detail)
22: R37 Collaborative Research, Development, and License HTML 46K
Agreements - Additional Information (Detail)
57: R38 Leases - Additional Information (Details) HTML 58K
39: R39 Leases - Schedule of Impact of Adoption of ASC 842 HTML 45K
on Consolidated Balance Sheet (Details)
51: R40 Leases - Summary of Lease Liabilities and HTML 39K
Corresponding Right-of-use assets (Details)
42: R41 Leases - Summary of Cash Flows Associated with HTML 22K
Company's Leases (Details)
14: R42 Leases - Future Lease Payments Relating to HTML 44K
Operating Lease Liabilities (Detail)
31: R43 Related Parties - Additional Information (Detail) HTML 41K
49: R44 Restructuring - Additional Information (Details) HTML 40K
40: R45 Restructuring - Summary of Restructuring Charges HTML 32K
Recorded in Selling, General and Administrative
Expenses (Details)
12: R46 Restructuring - Summary of Activity and Balances HTML 34K
of Restructuring Reserve (Details)
29: R47 Subsequent Events - Additional Information HTML 46K
(Detail)
32: XML IDEA XML File -- Filing Summary XML 108K
27: EXCEL IDEA Workbook of Financial Reports XLSX 72K
5: EX-101.INS XBRL Instance -- onvo-20190930 XML 1.69M
7: EX-101.CAL XBRL Calculations -- onvo-20190930_cal XML 112K
8: EX-101.DEF XBRL Definitions -- onvo-20190930_def XML 519K
9: EX-101.LAB XBRL Labels -- onvo-20190930_lab XML 972K
10: EX-101.PRE XBRL Presentations -- onvo-20190930_pre XML 813K
6: EX-101.SCH XBRL Schema -- onvo-20190930 XSD 137K
60: ZIP XBRL Zipped Folder -- 0001564590-19-041723-xbrl Zip 131K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Organovo Holdings, Inc. (the “Company”) for the period ended September 30, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Taylor Crouch, Chief Executive Officer and President and I, Craig Kussman, Chief Financial Officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 7, 2019
|
/s/ Taylor Crouch |
|
Chief Executive Officer and President (Principal Executive Officer) |
|
/s/ Craig Kussman |
|
Chief Financial Officer (Principal Financial Officer) |
A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/7/19 | None on these Dates | ||
| For Period end: | 9/30/19 | |||
| List all Filings | ||||